# PET/MRI Imaging of Glutamate Release in the Brain

> **NCT02511691** · PHASE2 · TERMINATED · sponsor: **University of Zurich** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 18F-PSS232

## Key facts

- **NCT ID:** NCT02511691
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2016-03-03
- **Final completion:** 2016-03-03
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Enough data for a publication, decision of Sponsor-PI
- **Last updated:** 2020-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02511691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02511691, "PET/MRI Imaging of Glutamate Release in the Brain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02511691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*